Clinical utility of the cold pressor test: evaluation of pain patients, treatment of opioid-induced hyperalgesia and fibromyalgia with low dose naltrexone

Discov Med
November 2018
https://pubmed.ncbi.nlm.nih.gov/30695679/

Opioid antagonists as potential therapeutics for ischemic stroke

Prog Neurobiol
November 2009
https://pubmed.ncbi.nlm.nih.gov/31398359/#

Early outcomes following low dose naltrexone enhancement of opioid detoxification

Am J Addict
April 2009
https://pubmed.ncbi.nlm.nih.gov/19283561/

Safety and tolerability of ALO-02 (oxycodone hydrochloride and sequestered naltrexone hydrochloride) extended-release capsules in older patients: a pooled analysis of two clinical trials

Curr Med Res Opinl
17 September 2019
https://pubmed.ncbi.nlm.nih.gov/31456431/

Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy

Int Immunopharmacol
09 August 2019
https://pubmed.ncbi.nlm.nih.gov/31404891/

The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal

Am J Drug Alcohol Abuse
May 2012
https://pubmed.ncbi.nlm.nih.gov/22233189/

Effects of low-dose naltrexone on feed intake, growth, endocrine and immune parameters in the recently-weaned pig

Masters Thesis, University of Tennessee, Knoxville
December 2015
https://www.semanticscholar.org/paper/Effects-of-low-dose-naltrexone-on-feed-intake%2C-and-Carter/c487fc0f07daaed24e0ba8693e18d37ed369303b

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients

Int J Pharm Compd
May-June 2016
https://www.ncbi.nlm.nih.gov/pubmed/28333660

Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy

Int J Oncol
August 2016
https://www.ncbi.nlm.nih.gov/pubmed/27279602